<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:16:40Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15475" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/15475</identifier><datestamp>2026-10-18T21:14:27Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome</dc:title><dc:creator>Bakirci, Eftal Murat</dc:creator><dc:creator>Ünver, Edhem</dc:creator><dc:creator>Deʇirmenci, Hüsnü</dc:creator><dc:creator>Kivanç, Tülay</dc:creator><dc:creator>Günay, Murat</dc:creator><dc:creator>Hamur, Hikmet</dc:creator><dc:creator>Büyüklü, Mutlu</dc:creator><dc:creator>Ceyhun, Gökhan</dc:creator><dc:creator>Topal, Ergun</dc:creator><dc:creator>Çoban, Taha Abdulkadir</dc:creator><dc:subject>Carotid intima-media thickness</dc:subject><dc:subject>Coronary artery disease</dc:subject><dc:subject>Inflammation</dc:subject><dc:subject>Obstructive</dc:subject><dc:subject>Sleep apnea</dc:subject><dc:subject>YKL-40</dc:subject><dc:subject>Adipokines</dc:subject><dc:subject>Adult</dc:subject><dc:subject>Atherosclerosis</dc:subject><dc:subject>Female</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Lectins</dc:subject><dc:subject>Male</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>Polysomnography</dc:subject><dc:subject>Prospective Studies</dc:subject><dc:subject>Sleep Apnea, Obstructive</dc:subject><dc:subject>biological marker</dc:subject><dc:subject>C reactive protein</dc:subject><dc:subject>chitinase 3 like protein 1</dc:subject><dc:subject>unclassified drug</dc:subject><dc:subject>adipocytokine</dc:subject><dc:subject>CHI3L1 protein, human</dc:subject><dc:subject>lectin</dc:subject><dc:subject>apnea hypopnea index</dc:subject><dc:subject>arterial wall thickness</dc:subject><dc:subject>Article</dc:subject><dc:subject>B scan</dc:subject><dc:subject>blood level</dc:subject><dc:subject>body mass</dc:subject><dc:description>Objective: The inflammatory process plays an important role in the development of cardiovascular complications in patients with obstructive sleep apnea syndrome (OSAS). YKL-40/chitinase 3-like protein 1 is a novel biomarker of systemic inflammation. This study aimed to investigate whether carotid intima-media thickness (CIMT), a useful marker for early atherosclerosis, is associated with serum YKL-40/chitinase 3-like protein 1 levels in patients with normotensive and nondiabetic OSAS. Methods: The study included 40 OSAS patients and 40 age-sex- and body mass index-matched healthy controls. Serum YKL-40 levels were detected by enzyme-linked immunosorbent assay. CIMT was measured by B-mode ultrasound. Results: The patients with OSAS had significantly increased CIMT and higher YKL-40 and high sensitivity C-reactive protein (hsCRP) levels than those of the controls. CIMT was strongly correlated with serum YKL-40 levels (r=0.694, p&lt;0.001), hsCRP (r=0.622, p&lt;0.001), age (r=0.525, p=0.001), and weakly correlated with apnea-hypopnea index (AHI) (r=0.365, p=0.021) and the percentage of recording time spent (PRTS) of oxygen saturation &lt;90% (r=0.488, p=0.001). Moreover, it was detected that serum YKL-40 levels were strongly correlated with AHI (r=0.617, p&lt;0.001), and weakly correlated with SaO2 &lt;90% of PRTS (r=0.394, p=0.012) and hsCRP (r=0.486, p=0.001). In multiple regression analyses, age and serum levels of YKL-40 and hsCRP were found to be independent predictors of CIMT. Conclusion: In patients with OSAS, CIMT was increased. This increase was associated with serum YKL-40 level. Increased serum level of YKL-40 may be an early predictor of atherosclerosis development in patients with OSAS. © 2015 Türk Kardiyoloji Derneʇí.</dc:description><dc:publisher>Turkish Society of Cardiology</dc:publisher><dc:date>2015</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/15475</dc:identifier><dc:identifier>https://doi.org/10.5543/tkda.2015.56805</dc:identifier><dc:identifier>1016-5169</dc:identifier><dc:language>en</dc:language><dc:relation>Turk Kardiyoloji Dernegi Arsivi</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/15475</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>